Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Document -

Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.
  • License: © All rights reserved
    The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
  • File format: .pdf

Contacts

Jan Hermansson

Press contact Global Marketing Manager +46703778337

Related content

Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.